159 related articles for article (PubMed ID: 36914901)
21. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
22. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
23. Mechanism exploration and prognosis study of Astragali Radix-Spreading hedyotis herb for the treatment of lung adenocarcinoma based on bioinformatics approaches and molecular dynamics simulation.
Guo J; Zhao Y; Wu X; Li G; Zhang Y; Song Y; Du Q
Front Chem; 2023; 11():1128671. PubMed ID: 37065830
[No Abstract] [Full Text] [Related]
24. Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.
Zhang L; Liu Y; Zhuang JG; Guo J; Li YT; Dong Y; Song G
World J Clin Cases; 2023 Aug; 11(23):5504-5518. PubMed ID: 37637684
[TBL] [Abstract][Full Text] [Related]
25. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
[TBL] [Abstract][Full Text] [Related]
26. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Dai D; Shi R; Han S; Jin H; Wang X
Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
[TBL] [Abstract][Full Text] [Related]
27. Core genes in lung adenocarcinoma identified by integrated bioinformatic analysis.
Yang L; Yu Q; Zhu Y; Ali Mallah M; Wang W; Feng F; Zhang Q
Int J Environ Health Res; 2023 Mar; 33(3):243-257. PubMed ID: 34961365
[TBL] [Abstract][Full Text] [Related]
28. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
29. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
30. The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking.
Du L; Xiao Y; Xu Y; Chen F; Chu X; Cao Y; Zhang X
Front Med (Lausanne); 2021; 8():813119. PubMed ID: 35127768
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis.
Guo P; Xu T; Jiang Y; Shen W
Transl Cancer Res; 2022 Jan; 11(1):227-241. PubMed ID: 35261899
[TBL] [Abstract][Full Text] [Related]
32. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
[TBL] [Abstract][Full Text] [Related]
33. Identification of key genes associated with lung adenocarcinoma by bioinformatics analysis.
Wang X; Yang J; Gao X
Sci Prog; 2021; 104(1):36850421997276. PubMed ID: 33661044
[TBL] [Abstract][Full Text] [Related]
34. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract][Full Text] [Related]
35. The Regulatory Network of Gastric Cancer Pathogenesis and Its Potential Therapeutic Active Ingredients of Traditional Chinese Medicine Based on Bioinformatics, Molecular Docking, and Molecular Dynamics Simulation.
Yang P; Liu P; Li J
Evid Based Complement Alternat Med; 2022; 2022():5005498. PubMed ID: 36471693
[TBL] [Abstract][Full Text] [Related]
36. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
37.
Tan Z; Chen M; Wang Y; Peng F; Zhu X; Li X; Zhang L; Li Y; Liu Y
Biomark Med; 2022 Feb; 16(2):83-100. PubMed ID: 34882011
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
39. Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis.
Yang FR; Li SY; Hu XW; Li XR; Li HJ
Drug Des Devel Ther; 2022; 16():2365-2382. PubMed ID: 35910781
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics study on genes related to a high-risk postoperative recurrence of lung adenocarcinoma.
Lin X; Zhou M; Xu Z; Chen Y; Lin F
Sci Prog; 2021; 104(3):368504211018053. PubMed ID: 34304612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]